Zentalis Pharmaceuticals (ZNTL) Return on Capital Employed (QoQ) (2020 - 2026)

Zentalis Pharmaceuticals (ZNTL) Return on Capital Employed (QoQ) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Zentalis Pharmaceuticals 302.14 Mn 302.14 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -524.00
Dec 31, 2025 -161.00
Sep 30, 2025 97.00
Jun 30, 2025 364.00
Mar 31, 2025 -997.00
Dec 31, 2024 96.00
Sep 30, 2024 -210.00
Jun 30, 2024 372.00
Mar 31, 2024 810.00
Dec 31, 2023 -796.00
Sep 30, 2023 255.00
Jun 30, 2023 -339.00
Mar 31, 2023 -359.00
Dec 31, 2022 -234.00
Sep 30, 2022 780.00
Jun 30, 2022 491.00
Mar 31, 2022 -394.00
Dec 31, 2021 1,114.00
Sep 30, 2021 105.00
Jun 30, 2021 -1,760.00